SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028717
Filing Date
2018-11-09
Accepted
2018-11-09 06:05:24
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vsar-10q_20180930.htm 10-Q 1428765
2 EX-31.1 vsar-ex311_7.htm EX-31.1 16984
3 EX-31.2 vsar-ex312_79.htm EX-31.2 17074
4 EX-32.1 vsar-ex321_6.htm EX-32.1 4791
5 EX-32.2 vsar-ex322_80.htm EX-32.2 4899
  Complete submission text file 0001564590-18-028717.txt   4169391

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vsar-20180930.xml EX-101.INS 736495
7 XBRL TAXONOMY EXTENSION SCHEMA vsar-20180930.xsd EX-101.SCH 32880
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20180930_cal.xml EX-101.CAL 30532
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20180930_def.xml EX-101.DEF 88500
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20180930_lab.xml EX-101.LAB 231622
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20180930_pre.xml EX-101.PRE 178339
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 181171252
SIC: 2834 Pharmaceutical Preparations